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Effects of d-amphetamine on quantitative 
measures of motor performance 
The effects of 10 mg. of d-amphetamine and a placebo of similar appearance were determined 
by means of a battery of quantitative objective measures of motor performance in normal 
volunteers. The medication was administered in a random, double-blind, crossover design 
on two occasions one week apart. No significant differences between the effects of the 
medications on resting and sustention tremor or precision hole steadiness were found. However, 
several compematory tracking tasks which required su.stained concentration and motor 
coordination were significantly improved with d-amphetamine. 
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It is well known that d-amphetamine in 
proper dosage and circumstance improves 
human performance on certain behavioral 
tasks.1 • 11 The effects depend on the dose 
and mental state of the individual. Oral 
doses in the order of 10 to 30 mg. may 
reverse behavioral decrements due to fa-
tigue and sleep loss, 4 increase wakefulness, 
and increase motor activity. Performance 
of simple mental tasks may be improved, 
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although the number of errors is not neces-
sarily decreased.12 In general, d-ampheta-
mine is known to improve performance in 
human beings which requires attention de-
spite continued boredom. 3• 6 Although many 
behavioral tasks have been used in study-
ing the effects of d-amphetamine in man, 
there still is a need for precise measures of 
human motor performance. 
This paper describes some effects of a 
standard dose of d-amphetamine given 
orally on quantitative measures of motor 
performance in order to stimulate wide-
spread use of such tests in assessing am-
phetamine-like drugs. It was hypothesized 
that quantification of motor function would 
be a very accurate means of determining 
the effects of small doses of amphetamine 
in normal nonfatigued subjects. 
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Methods 
Six paid male graduate students partici-
pated as subjects. A medical history and 
physical examination were obtained for 
each subject to ensure normality for the 
purposes of the study. The subjects were 
tested on two occasions, one week apart. 
The oral medications were administered in 
a random, double-blind, crossover fashion. 
Each subject received 10 mg. of d-ampheta-
mine one week and a placebo of similar 
taste and appearance the other. They were 
told that they might receive either active 
or inactive material on one or both occa-
sions. Both experimenters and subjects were 
unaware of the order of medications; they 
knew only that an amphetamine-like drug 
might be given. 
Primary interest was to obtain objective 
measures of the effects of d-amphetamine 
on motor performance. The measures 
chosen were an extension of the Clinical 
Quantitative Neurological Examination de-
veloped by Tourtellotte and associates.5• 7• 
8
• 
10 The quantitative measures included 
tests of the following: 
1. Tremor-Measures of resting and sus-
tention tremor were obtained with the use 
of an accelerometer placed on the index 
finger of the dominant hand. Six 10 second 
trials were conducted for each test with the 
average score for the 6 trials used as the 
test measure. Scores were based on the 
average of Jhe absolute acceleration. Units 
are in G-se&mds per second, where G refers 
to the acceleration due to gravity. For a more 
complete description of the test apparatus 
in this and subsequent tests, see Potvin. 7 
2. Precision hole steadiness-The sub-
ject's ability to hold a stylus in a circular 
hole without touching the sides was used 
as a measure of steadiness. Both supported 
and unsupported conditions were used for 
static and dynamic positioning of the stylus. 
In the static task, the subject was required 
to hold the stylus in the smallest possible 
hole for 5 seconds without contacting the 
sides of the hole. In the dynamic task, the 
subject was required to insert the 3 inch 
stylus 2¥2 inches into the hole and then 
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withdraw it without contacting the sides. 
No time limit was placed on the dynamic 
task. Six trials were conducted for the 4 
tests. The steadiness measure for each of 
the test conditions was the difference be-
tween the diameter of the smallest hole for 
which the subject made no contact and the 
diameter of the stylus averaged over 2 
trials. Units were in ){28 of an inch. 
3. Tracking-Three compensatory track-
ing tasks were used to measure the subject's 
tracking ability. The constant-force tracking 
task required the subject to apply a con-
stant 300 Gm. force to a force stick. A 
meter was used to display to the subject 
his deviation from 300 Gm. during the test. 
Six 10 second trials were conducted for 
both supported and unsupported conditions. 
The score for a given trial was the average 
of the subject's absolute deviation from 
300 Gm. The average score for the six 
trials, recorded in gram-seconds per sec-
ond, was used as the test measure. 
The random tracking task required the 
subject to follow a random-appearing signal 
using a large position control stick. The dif-
ference between the subject's output and 
the desired output was displayed on an 
oscilloscope screen. Ten 45 second trials 
were used, the score for each trial being the 
average of the subject's absolute position 
error. The average score for the 10 trials, 
expressed in millimeter-seconds per second 
was used as the test measure. 
The critical tracking task required the 
subject to control a system which became 
increasingly unstable with time. The same 
display and control stick were used as in the 
random tracking task. The difference be-
tween the desired null output of the sys-
tem and actual output was displayed to the 
subject. When the subject could no longer 
keep the control error within the range of 
the screen, the test was automatically ter-
minated. Scores, given in reciprocal sec-
onds, reflect the highest degree of instabil-
ity controllable by the subject and are 
an approximate measure of the reciprocal of 
the subject's .effective time delay. The 
average of 10 trials was used as the test 
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Fig. 1. Effects of d-amphetamine on resting and sustention tremor. The mean data are given 
for a predrug (control), placebo, and 10 mg. of d-amphetamine in this and the subsequent 
figures. 
measure. For further description of the 
random and critical tracking tasks, see Repa 
and associates. 8 
The tests were conducted as follows: 
Subjects were asked to fast for 4 hours be-
fore the testing began. Then the complete 
test battery was conducted in the order 
described above, after which they were 
given d-amphetamine or placebo. The test 
battery took about one hour. After waiting 
90 minutes, the subjects were retested. A 
urine specimen was taken and the subjec-
tive responses of the subjects were re-
corded. The subjects returned one week 
later and repeated the same procedure, 
this time receiving the alternate medica-
tion. Performance scores were obtained 
both before and after drug administration 
on each of the test days to account for the 
variability in performance resulting from 
testing on different days. 
Results 
Subiective impressions. Subjects were 
asked whether or not they could distin-
guish any effects of the medications at the 
end of the placebo and d-amphetamine 
trials. Only 2 of the 6 subjects reported an 
effect following the d-amphetamine trial 
and no effect following the placebo trial. 
The others were unable to distinguish active 
drug from placebo. 
Quantitative measures. The quantitative 
measures, comparing the control scores to 
the scores obtained after placebo and d-am-
phetamine administration are summarized 
in Table I. Paired t tests were performed 
on the mean differences between placebo 
scores and d-amphetamine scores as well 
as on the mean differences between changes 
in scores following placebo and d-ampheta-
mine administration. The results of these 
tests are also shown in Table I. The mea-
sures will be considered individually. 
Tremor. The scores for the tremor tests 
shown in Table I are displayed in Fig. 1. 
For resting tremor, neither the differences 
between d-amphetamine scores and placebo 
nor the difference in the changes in scores 
following d-amphetamine and placebo ad-
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Fig. 2. Effects of d-amphetamine on precision hole steadiness. 
ministration was statistically significant. 
For sustention tremor there was a signifi-
cant difference between d-amphetamine 
scores and placebo scores ( t = 3.12, p < 
0.05). However, examination of the susten-
tion tremor control data indicates the large 
variability in this measure from one week 
to the next, suggesting that the change in 
sustention tremor following administration 
of placebo and d-amphetamine may be the 
more meaningful measure. When this mea-
sure was used there was no significant dif-
ference between d-amphetamine and pla-
cebo, although there was a slight trend for 
placebo to decrease sustention tremor to a 
greater extent than d-amphetamine. 
Precision hole steadiness. The data for 
the precision hole steadiness tests are dis-
played graphically in Fig. 2 and numerical-
ly in Table I. There were no statistically 
significant differences between performance 
after placebo and after d-amphetamine 
for any of the measures, based either on ab-
solute scores or changes in scores. In the 
static supported task, placebo performance 
was better than control performance, 
while d-amphetamine produced no change. 
This task required minimal motor output 
and is thought to be more sensitive to rest-
ing tremor levels than the other hole steadi-
ness tests. In the three remaining steadiness 
tests, there was a tendency for both medi-
cations to improve performance, with 
d-amphetamine causing greater improve-
ments in steadiness than placebo. These 3 
tasks require more muscular output and 
coordination than the static supported 
task. 
Tracking. The tracking scores are shown 
numerically in Table I and graphically in 
Fig. 3. The performance in the d-amphet-
amine trials tends to be better than that in 
the placebo trials for each of the tests based 
on both absolute scores and changes in 
scores. The change in performance with d-
amphetamine was significantly greater than 
that with placebo for both the unsupported 
constant force task and the critical task ( p 
< 0.05). There was also a significant dif-
ference in the absolute scores for d-am-
256 Domino et al. 
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Fig. 3. Effects of d-amphetamine on tracking behavior under various conditions. 
phetamine and placebo in the unsupported 
constant force task ( p < 0.05). 
Urinary pH. At the end of 2¥2 hours 
after ingestion of either the placebo or a-
amphetamine capsule, urinary pH was 
found to range from 6 to 7 for all subjects. 
Discussion 
A comparison has been made of absolute 
measures of tremor, precision hole steadi-
ness, and tracking, as well as of changes in 
these measures following oral administra-
tion of placebo and 10 mg. of a-ampheta-
mine in a double-blind, crossover trial. The 
data suggest that at the time of examina-
tion no significant changes in measures of 
tremor, resting and sustention, or precision 
hole steadiness can be attributed to a-am-
phetamine. However, several compensatory 
tracking tasks requiring sustained concen-
tration and motor coordination did show 
significantly better performance after a-
amphetamine than after placebo. Those 
tracking tasks that did not show statistical-
ly significant differences, however, did 
show performance trends in favor of a-
amphetamine. It appears that a 10 mg. 
dose of d-amphetamine does not signifi-
cantly affect tremor or motor perform-
ance in tasks of short duration and mini-
mal motor output. However, such a dose 
appears to significantly improve perform-
ance in complex motor tasks requiring 
more sustained subject attention and co-
operation. The use of sensitive, quantitative 
testing procedures for evaluating small 
changes in motor performance is clearly 
justified. Of course, in evaluating over-all 
drug effects some measure of mood is also 
indicated. 
These data are in line with previous ob-
servations in the literature.11 The advantage 
of some of the tasks described in this manu-
script is their simplicity and especially their 
quantitative precision. Other compounds 
related to amphetamine would be of in-
terest to compare. 
It has been pointed out by Rowland and 
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Beckett9 that the oral absorption of d-am-
phetamine is complete about llh to 2lh 
hours after ingestion. It is for this reason 
that our subjects were studied between 
llh to 2lh hours after drug administration. 
It should also be pointed out that all of our 
subjects had a urinary pH between 6 and 7 
at the end of the experimental session. 
Probably the variability in excretion due to 
changes in urinary pH therefore was de-
creased. Although the mechanisms of d-am-
phetamine action are very complex, 2 the 
drug clearly produces behavioral effects in 
relatively small dosage in normal non-
fatigued subjects. 
References 
1. Adler, H. F., Burckhardt, W. L., Ivy, A. C., 
and Atkinson, A. J.: Effect of various drugs 
on psychomotor performance at ground level 
and simulated altitudes of 18,000 feet in a low 
pressure chamber, Aviation Med. 21:221-236, 
1950. 
2. Costa, E., and Garattini, S.: International 
symposium on amphetamine related com-
pounds, New York, 1970, Raven Press. 
3. Eysenck, H. J., Casey, S., and Trouton, D. S.: 
Drugs and personality. IV. The effects of 
stimulant and depressant drugs on continuous 
work, J. Ment. Sci. 103:645-649, 1957. 
4. Kornetsky, C., Mirsky, A. F., Kessler, E. K., 
and Dorff, J. E.: The effects of dextro-am-
phetamine on behavioral deficits produced by 
sleep loss in humans, J. Pharmacal. Exp. Ther. 
127:46-54, 1959. 
5. Kuzma, J. W., Tourtellotte, W. W., and Rem-
Measures of motor performance 257 
ington, R. D.: Quantitative clinical neuro-
logical testing. II. Some statistical considera-
tions of a battery of tests, J. Chron. Dis. 18: 
303-311, 1965. 
6. Payne, R. B., Hauty, G. T., and Moore, E. W.: 
Restoration of tracking proficiency as a func-
tion of amount and delay of analeptic medica-
tion, J. Comp. Physiol. Psychol. 50:145-149, 
1957. 
7. Potvin, A. R.: The effects of age, motivation, 
and learning on performance in the quantita-
tive examination of neurological function. 
Doctoral dissertation, The University of Michi-
gan, Ann Arbor, 1971. 
8. Repa, B. S., Albers, J. W., Potvin, A. R., and 
Tourtellotte, W. W.: The use of a battery of 
tracking tests in the quantitative evaluation of 
neurological function. Seventh Annual NASA-
University Conference on Manual Control, The 
University of Southern California, Los Angeles, 
California, June 2 to 4, 1971. 
9. Rowland, M., and Beckett, A. H.: The am-
phetamines: Clinical and pharmacokinetic im-
plications of recent studies of an assay proce-
dure and urinary excretion in man, Arzneim. 
Forsch. 16:1369-1373, 1966. 
10. Tourtellotte, W. W., Haerer, A. F., Simpson, 
J. F., Kuzma, J. W., and Sikorski, J.: Quantita-
tive clinical neurological testing. I. A study of 
a battery of tests designed to evaluate in part 
the neurological functions of patients with 
multiple sclerosis and its use in a therapeutic 
trial, Ann. N. Y. Acad. Sci. 122:480-505, 1965. 
11. Weiss, B., and Laties, V. G.: Enhancement of 
human performance by caffeine and the 
amphetamines, Pharmacal. Rev. 14:1-36, 1962. 
12. Willett, R. A.: The effect of a stimulant and 
a depressant drug on the serial rote learning 
of nonsense syllables, Psychopharmacologia 
3:23-34, 1962. 
